Top section
Top section
Streamlining of IPO process just two months after consultation closed as the market prepares for post-summer IPO activity
Sale comes after the expiry last month of a pre-emptive acquisition rights agreement between the main family holding companies
Placing and open offer follows recent acquisition of US annuity provider
More articles
More articles
More articles
-
The Covid-19 crisis, and particularly the equity rally since the bottom of the sell-off in March, should cause deep reflection for active fund managers at risk of underperforming if they stick to their principles. -
Healthy financial systems should not rely on short sellers and journalists to expose accounting scandals at large, publicly listed companies. Regulators and auditors should have been the heroes of the Wirecard story but their inability to see what others saw plainly paints them as the villains in this edition of German corporate noir.
-
Banks are hoping that there will be more European primary capital raising in the weeks ahead as companies begin to assess what will be needed to rebuild their balance sheets and whether the time is ripe for growth. A €341m share trade in German firm CompuGroup Medical on Monday night may show a way forward for issuers.
-
Zhen Ding Technology Holding tapped the equity-linked market on Monday with a zero coupon convertible bond.
-
German pharmaceuticals company Boehringer Ingelheim has sold its remaining stake in UK drug maker Hikma Pharmaceuticals, after a surge in investor interest in pharma stocks during the Covid-19 global pandemic.
-
China’s ChiNext board, which focuses on innovative companies and start-ups, has started accepting listing applications as it kicks off a reform centred on a registration-based IPO system.
Sub-sections
shared comment list
